PDCD1 and cancer: Patients with cachexia exhibited worse overall response rate (ORR) and progression free survival (PFS) values than those without it, even if they were potentially sensitive to anti‐programed cell death 1/programed cell death ligand 1 (PD‐1/PD‐L1) inhibitor and have high PD‐L1 expression in cancer cells.